SAN ANTONIO – Once-weekly tirzepatide (Zepbound) reduced the risk for progression from prediabetes to type 2 diabetes (T2D) ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Only 12% of the nurses providing patient care at hospitals and health clinics today are men. Although the percentage of ...

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...

Sunir J. Garg, MD, reflects on the recent American Academy of Ophthalmology meeting in Chicago and shares key insights on managing diabetic macular edema (DME). Dr Garg highlights new data showing ...

Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic ...

Weight loss interventions using medication or behavioral changes can improve insulin resistance, hormonal markers, and ...

A growing body of research explores the link between stroke risk and regular consumption of coffee, tea, soda, and alcohol.

Masking during intravitreal anti-VEGF injections was associated with a similar incidence of endophthalmitis compared to not ...

IBS has classically been regarded as a “diagnosis of exclusion,” but new research suggested that might be changing with better diagnostic and treatment approaches.

SAN ANTONIO, Texas — An upcoming document will entirely reframe obesity as a “condition of excess adiposity” that constitutes a disease called “clinical obesity” when related tissue and organ ...

In women with polycystic ovary syndrome (PCOS) and with obesity or overweight, the combination of topiramate and metformin along with a low-calorie diet can result in effective weight loss and improve ...